Furet P - Search Results

1

Urea derivatives of STI571 as inhibitors of Bcr-Abl and PDGFR kinases.

Manley PW, Breitenstein W, Brüggen J, Cowan-Jacob SW, Furet P, Mestan J, Meyer T. Manley PW, et al. Among authors: furet p. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5793-7. doi: 10.1016/j.bmcl.2004.09.042. Bioorg Med Chem Lett. 2004. PMID: 15501042

2

Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase.

Trinks U, Buchdunger E, Furet P, Kump W, Mett H, Meyer T, Müller M, Regenass U, Rihs G, Lydon N, et al. Trinks U, et al. Among authors: furet p. J Med Chem. 1994 Apr 1;37(7):1015-27. doi: 10.1021/jm00033a019. J Med Chem. 1994. PMID: 8151612

3

4-Amidinoindan-1-one 2'-amidinohydrazone: a new potent and selective inhibitor of S-Adenosylmethionine decarboxylase.

Stanek J, Caravatti G, Frei J, Furet P, Mett H, Schneider P, Regenass U. Stanek J, et al. Among authors: furet p. J Med Chem. 1993 Jul 23;36(15):2168-71. doi: 10.1021/jm00067a014. J Med Chem. 1993. PMID: 8340919

4

4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.

Traxler PM, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N. Traxler PM, et al. Among authors: furet p. J Med Chem. 1996 Jun 7;39(12):2285-92. doi: 10.1021/jm960118j. J Med Chem. 1996. PMID: 8691423

5

Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.

Traxler P, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N. Traxler P, et al. Among authors: furet p. J Pharm Belg. 1997 Mar-Apr;52(2):88-96. J Pharm Belg. 1997. PMID: 9193132 Review.

6

Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.

Traxler P, Bold G, Frei J, Lang M, Lydon N, Mett H, Buchdunger E, Meyer T, Mueller M, Furet P. Traxler P, et al. Among authors: furet p. J Med Chem. 1997 Oct 24;40(22):3601-16. doi: 10.1021/jm970124v. J Med Chem. 1997. PMID: 9357527

7

Potent antagonists of the SH2 domain of Grb2: optimization of the X+1 position of 3-amino-Z-Tyr(PO3H2)-X+1-Asn-NH2.

García-Echeverría C, Furet P, Gay B, Fretz H, Rahuel J, Schoepfer J, Caravatti G. García-Echeverría C, et al. Among authors: furet p. J Med Chem. 1998 May 21;41(11):1741-4. doi: 10.1021/jm970856n. J Med Chem. 1998. PMID: 9599224 No abstract available.

8

Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain.

Schoepfer J, Gay B, Caravatti G, Garcia-Echeverria C, Fretz H, Rahuel J, Furet P. Schoepfer J, et al. Among authors: furet p. Bioorg Med Chem Lett. 1998 Oct 20;8(20):2865-70. doi: 10.1016/s0960-894x(98)00513-7. Bioorg Med Chem Lett. 1998. PMID: 9873638

9

2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors.

Imbach P, Capraro HG, Furet P, Mett H, Meyer T, Zimmermann J. Imbach P, et al. Among authors: furet p. Bioorg Med Chem Lett. 1999 Jan 4;9(1):91-6. doi: 10.1016/s0960-894x(98)00691-x. Bioorg Med Chem Lett. 1999. PMID: 9990463

10

Highly potent inhibitors of the Grb2-SH2 domain.

Schoepfer J, Fretz H, Gay B, Furet P, García-Echeverría C, End N, Caravatti G. Schoepfer J, et al. Among authors: furet p. Bioorg Med Chem Lett. 1999 Jan 18;9(2):221-6. doi: 10.1016/s0960-894x(98)00701-x. Bioorg Med Chem Lett. 1999. PMID: 10021933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters